IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-48721-3.html
   My bibliography  Save this article

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Author

Listed:
  • Barnabas G. Williams

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Lloyd D. W. King

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • David Pulido

    (University of Oxford, Old Road Campus Research Building)

  • Doris Quinkert

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Amelia M. Lias

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Sarah E. Silk

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Robert J. Ragotte

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    University of Oxford, Old Road Campus Research Building)

  • Hannah Davies

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Jordan R. Barrett

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Kirsty McHugh

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Cassandra A. Rigby

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford)

  • Daniel G. W. Alanine

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    University of Oxford, Old Road Campus Research Building)

  • Lea Barfod

    (University of Oxford, Old Road Campus Research Building)

  • Michael W. Shea

    (University of Oxford, Old Road Campus Research Building)

  • Li An Cowley

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    University of Oxford, Old Road Campus Research Building)

  • Rebecca A. Dabbs

    (University of Oxford, Old Road Campus Research Building)

  • David J. Pattinson

    (University of Oxford, Old Road Campus Research Building)

  • Alexander D. Douglas

    (University of Oxford, Old Road Campus Research Building)

  • Oliver R. Lyth

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    University of Oxford, Old Road Campus Research Building)

  • Joseph J. Illingworth

    (University of Oxford, Old Road Campus Research Building)

  • Jing Jin

    (University of Oxford, Old Road Campus Research Building)

  • Cecilia Carnrot

    (SE-753 18)

  • Vinayaka Kotraiah

    (Leidos Life Sciences)

  • Jayne M. Christen

    (Leidos Life Sciences)

  • Amy R. Noe

    (Leidos Life Sciences
    Latham BioPharm Group)

  • Randall S. MacGill

    (PATH)

  • C. Richter King

    (PATH)

  • Ashley J. Birkett

    (PATH)

  • Lorraine A. Soisson

    (1300 Pennsylvania Ave. NW)

  • Katherine Skinner

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building)

  • Kazutoyo Miura

    (NIAID/NIH)

  • Carole A. Long

    (NIAID/NIH)

  • Matthew K. Higgins

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford)

  • Simon J. Draper

    (University of Oxford, Dorothy Crowfoot Hodgkin Building
    Dorothy Crowfoot Hodgkin Building, University of Oxford
    University of Oxford, Old Road Campus Research Building
    NIHR Oxford Biomedical Research Centre)

Abstract

Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) and RH5-interacting protein (RIPR) to form an essential heterotrimeric “RCR-complex”. We investigate whether RCR-complex vaccination can improve upon RH5 alone. Using monoclonal antibodies (mAbs) we show that parasite growth-inhibitory epitopes on each antigen are surface-exposed on the RCR-complex and that mAb pairs targeting different antigens can function additively or synergistically. However, immunisation of female rats with the RCR-complex fails to outperform RH5 alone due to immuno-dominance of RIPR coupled with inferior potency of anti-RIPR polyclonal IgG. We identify that all growth-inhibitory antibody epitopes of RIPR cluster within the C-terminal EGF-like domains and that a fusion of these domains to CyRPA, called “R78C”, combined with RH5, improves the level of in vitro parasite growth inhibition compared to RH5 alone. These preclinical data justify the advancement of the RH5.1 + R78C/Matrix-M™ vaccine candidate to Phase 1 clinical trial.

Suggested Citation

  • Barnabas G. Williams & Lloyd D. W. King & David Pulido & Doris Quinkert & Amelia M. Lias & Sarah E. Silk & Robert J. Ragotte & Hannah Davies & Jordan R. Barrett & Kirsty McHugh & Cassandra A. Rigby & , 2024. "Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48721-3
    DOI: 10.1038/s41467-024-48721-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-48721-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-48721-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Robert J. Ragotte & David Pulido & Amelia M. Lias & Doris Quinkert & Daniel G. W. Alanine & Abhishek Jamwal & Hannah Davies & Adéla Nacer & Edward D. Lowe & Geoffrey W. Grime & Joseph J. Illingworth &, 2022. "Heterotypic interactions drive antibody synergy against a malaria vaccine candidate," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    2. Alexander D. Douglas & Andrew R. Williams & Joseph J. Illingworth & Gathoni Kamuyu & Sumi Biswas & Anna L. Goodman & David H. Wyllie & Cécile Crosnier & Kazutoyo Miura & Gavin J. Wright & Carole A. Lo, 2011. "The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody," Nature Communications, Nature, vol. 2(1), pages 1-9, September.
    3. Cécile Crosnier & Leyla Y. Bustamante & S. Josefin Bartholdson & Amy K. Bei & Michel Theron & Makoto Uchikawa & Souleymane Mboup & Omar Ndir & Dominic P. Kwiatkowski & Manoj T. Duraisingh & Julian C. , 2011. "Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum," Nature, Nature, vol. 480(7378), pages 534-537, December.
    4. Francis Galaway & Laura G. Drought & Maria Fala & Nadia Cross & Alison C. Kemp & Julian C. Rayner & Gavin J. Wright, 2017. "P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5," Nature Communications, Nature, vol. 8(1), pages 1-11, April.
    5. Katherine E. Wright & Kathryn A. Hjerrild & Jonathan Bartlett & Alexander D. Douglas & Jing Jin & Rebecca E. Brown & Joseph J. Illingworth & Rebecca Ashfield & Stine B. Clemmensen & Willem A. de Jongh, 2014. "Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies," Nature, Nature, vol. 515(7527), pages 427-430, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Tony Triglia & Stephen W. Scally & Benjamin A. Seager & Michał Pasternak & Laura F. Dagley & Alan F. Cowman, 2023. "Plasmepsin X activates the PCRCR complex of Plasmodium falciparum by processing PfRh5 for erythrocyte invasion," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    2. Jaishree Tripathi & Lei Zhu & Sourav Nayak & Michal Stoklasa & Zbynek Bozdech, 2022. "Stochastic expression of invasion genes in Plasmodium falciparum schizonts," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Mubasher Mohammed & Alexis Dziedziech & Diego Macedo & Frederik Huppertz & Ylva Veith & Zoé Postel & Elena Christ & Richard Scheytt & Tanja Slotte & Johan Henriksson & Johan Ankarklev, 2024. "Single-cell transcriptomics reveal transcriptional programs underlying male and female cell fate during Plasmodium falciparum gametocytogenesis," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    4. Prasun Kundu & Deboki Naskar & Shannon J. McKie & Sheena Dass & Usheer Kanjee & Viola Introini & Marcelo U. Ferreira & Pietro Cicuta & Manoj Duraisingh & Janet E. Deane & Julian C. Rayner, 2023. "The structure of a Plasmodium vivax Tryptophan Rich Antigen domain suggests a lipid binding function for a pan-Plasmodium multi-gene family," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    5. Robert J. Ragotte & David Pulido & Amelia M. Lias & Doris Quinkert & Daniel G. W. Alanine & Abhishek Jamwal & Hannah Davies & Adéla Nacer & Edward D. Lowe & Geoffrey W. Grime & Joseph J. Illingworth &, 2022. "Heterotypic interactions drive antibody synergy against a malaria vaccine candidate," Nature Communications, Nature, vol. 13(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48721-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.